Early upregulation of 18-kDa translocator protein in response to acute neurodegenerative damage in TREM2-deficient mice

Autor: Sara Belloli a, b, c, Maria Pannese d, Cecilia Buonsanti e, Chiara Maiorino e, Giuseppe Di Grigoli a, Assunta Carpinelli a, Cristina Monterisi f, Rosa Maria Moresco b, f, Paola Panina-Bordignon d.
Přispěvatelé: Belloli, S., Pannese, M., Buonsanti, C., Maiorino, C., Di Grigoli, G., Carpinelli, A., Monterisi, C., Moresco, R. M., Panina-Bordignon, P., Belloli, S, Pannese, M, Buonsanti, C, Maiorino, C, Di Grigoli, G, Carpinelli, A, Monterisi, C, Moresco, R, Panina Bordignon, P
Rok vydání: 2017
Předmět:
0301 basic medicine
Aging
Interleukin-1beta
18-kDa translocator protein
Triggering receptor expressed on myeloid cells 2
chemistry.chemical_compound
0302 clinical medicine
Neuroinflammation
Receptors
Immunologic

Membrane Glycoproteins
Microglia
biology
General Neuroscience
MPTP
Neurodegeneration
Up-Regulation
Parkinson disease
medicine.anatomical_structure
1-Methyl-4-phenyl-1
2
3
6-tetrahydropyridine

Acute Disease
Positron emission tomography
medicine.medical_specialty
Mice
Transgenic

03 medical and health sciences
Downregulation and upregulation
Internal medicine
medicine
Translocator protein
Animals
Parkinson Disease
Secondary

Neuroscience (all)
TREM2
Receptors
GABA-A

medicine.disease
Mice
Inbred C57BL

Disease Models
Animal

030104 developmental biology
Endocrinology
chemistry
Nerve Degeneration
Immunology
biology.protein
Neurology (clinical)
Neuron
Geriatrics and Gerontology
Carrier Proteins
Gene Deletion
030217 neurology & neurosurgery
Developmental Biology
Zdroj: Neurobiology of aging (Online) 53 (2017): 159–168. doi:10.1016/j.neurobiolaging.2017.01.010
info:cnr-pdr/source/autori:Sara Belloli a,b,c, Maria Pannese d, Cecilia Buonsanti e, Chiara Maiorino e, Giuseppe Di Grigoli a,b, Assunta Carpinelli a, Cristina Monterisi f, Rosa Maria Moresco b,c,f, Paola Panina-Bordignon d./titolo:Early upregulation of 18-kDa translocator protein in response to acute neurodegenerative damage in TREM2-deficient mice/doi:10.1016%2Fj.neurobiolaging.2017.01.010/rivista:Neurobiology of aging (Online)/anno:2017/pagina_da:159/pagina_a:168/intervallo_pagine:159–168/volume:53
DOI: 10.1016/j.neurobiolaging.2017.01.010
Popis: Mutations in the TREM2 gene confer risk for Alzheimer's disease and susceptibility for Parkinson's disease (PD). We evaluated the effect of TREM2 deletion in a 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine (MPTP)–induced PD mouse model, measuring neurodegeneration and microglia activation using a combined invivo imaging and postmortem molecular approach. In wild-type mice, MPTP administration induced a progressive decrease of [11C]FECIT uptake, culminating at day 7. Neuronal loss was accompanied by an increase of TREM2, IL-1β, and translocator protein (TSPO) transcript levels, [11C]PK11195 binding and GFAP staining (from day 2), and an early and transient increase of TNF-α, Galectin-3, and Iba-1 (from day 1). In TREM2 null (TREM2−/−) mice, MPTP similarly affected neuron viability and microglial cells, as shown by the lower level of Iba-1 staining in basal condition, and reduced increment of Iba-1, TNF-α, and IL-1β in response to MPTP. Likely to compensate for TREM2 absence, TREM2−/− mice showed an earlier increment of [11C]PK11195 binding and a significant increase of IL-4. Taken together, our data demonstrate a central role of TREM2 in the regulation of microglia response to acute neurotoxic insults and suggest a potential modulatory role of TSPO in response to immune system deficit.
Databáze: OpenAIRE